Navigation Links
Boffins Find Link Between Common Sleep Disorder and Hypertension

A new study by an international team of researchers has found evidence that people suffering from moderate to severe cases of a common sleep disorder called restless legs syndrome (RLS) are at significantly increased risk for developing hypertension.

RLS is a common and debilitating sleep disorder that adversely affects the lives of tens of millions of people worldwide. It produces an intense, often irresistible urge to move the legs because of creeping, crawling, tingling or burning sensations. RLS causes considerable discomfort, insomnia and sleep disruption in people of all ages, and symptoms can occur when people are awake or asleep.

The 4-year joint study was led by boffins at Emory University who conducted the research along with colleagues at deCODE Genetics, Inc., an Icelandic genomics company, and Icelandic physicians at Landspitali in Reykjavik. The research team recruited 900 Icelanders for the study. Participants provided clinical information and the number of PLMs they experienced per hour of sleep over a period of two to five nights were measured. Age, gender, body mass index (BMI), and PLMs were examined as predictors of hypertension.

Researchers found the likelihood of hypertension increased with PLMs severity by 50 percent in participants who experienced more than 30 PLMs per hour of sleep. Older age and higher BMI were associated with increased hypertension risk as has been shown by others, yet, PLMs were associated with hypertension status independent of these two factors.

David Rye, MD, PhD, professor of neurology at Emory University School of Medicine, director of the Emory Program in Sleep and lead author of the study, says the association between RLS and increased risk for high blood pressure was confirmed with the new study. "Our results confirm and extend accumulating evidence that periodic leg movements of sleep (PLMs) seen in most RLS patients are associated with increased release of
'"/>




Page: 1 2

Related medicine news :

1. Fizzy Logic For A Perfect Drink: Courtesy Boffins
2. Boffins Identify Fifth Gene Behind Joubert Syndrome
3. Link Between Infection And Heart Disease
4. Prescription Drug Use Varies Widely Between States
5. Wait Between Pregnancies
6. Link Between Migraines and Behavioral Disorders
7. Link Between Obesity and Behavior in Kids
8. Link Between Mothers Depression and Violence in Children
9. Link Between Alcohol and Decrease in Brain Size
10. Link Between Musculoskeletal Pain and Vitamin D Deficiency
11. Link Between Hyperglycemia & Hospital Mortality
Post Your Comments:
(Date:5/12/2008)...thority Over Tobacco, WASHINGTON, May 9 /PRNews...c faith-based organization in the country, today a...moking Prevention and Tobacco Control,Act." The le...cco products., "We encourage Congress to pass t... broad bi-partisan support and could genuinely hel...
(Date:5/11/2008)...-- As the global community observes,the destructiv...one of all,time and the associated mounting frustr...ctims, the Alumni Myanmar Institutes of Medicine A...ortantly, successful-in initiating,medical care at... people,are assumed dead. AMIMA has funded the tra...
(Date:5/11/2008)... The winners of today,s Susan G.,Komen Pittsburgh ... Overall Winners Male: Pat McGuire, Charlott...n, Pittsburgh, Pa., 19:19, 2nd Place Overall Winn...Anna Beck, Washington, Pa., 19:22, 3rd Place Over...a., 16:13 Female: Jessica Winter, Pittsburgh...
(Date:5/11/2008)...for Unveiling of the New Name of the ...AGO, May 11 /PRNewswire/ -- Thousands of people ho...y were present for the unveiling of the,new name a...ancer,organization, This year, Y-ME National Brea...nniversary. In celebration of this landmark, Y-ME ...
Breaking Medicine News(10 mins):Health News:Alumni Myanmar Institutes of Medicine Association (AMIMA) Races Time to Help Cyclone Victims 2Health News:16th Annual Komen Pittsburgh Race for the Cure(R) Winners Announced 2Health News:Y-ME Makes Historic Announcement on Mother's Day 2Health News:Y-ME Makes Historic Announcement on Mother's Day 3
...enagers not to have sex until they get married is ...ess for Sexual Health' meeting in Sydney. // Willi...ormation and Education Council of the US, told del...ned by the US Congress found that the hundreds of ...
...-The day of reckoning is only getting closer for t...re closing in on them. //The most recent, is the o...ey have asked for a review of the information prov...nence Only Sex Education’ programme. The ACLU put ...
...og referred to as ‘chemo brain’ that chemotherapy ...tention it deserves. // Patients especially women...tive symptoms such as short-term memory loss, an i...rieving words, trouble with multitasking and an ov...
...s in Melbourne have found a breakthrough method of...st is done by measuring the proteins //in blood mu... a team of Howard Florey Institute, Mental Health ...rsity specialists. They have also created a genet...
Other Medicine News:Health News:Chemo Brain- Nothing Forgettable About It 2Health News:Chemo Brain- Nothing Forgettable About It 3Health News:New Blood Test to Diagnose Parkinson Disease 2
(Date:5/9/2008)... SAN DIEGO, May 9 /- A... focused on the discovery and development of,small...cancer and,inflammatory diseases, including gout, ...ed Senior Vice President, Finance and Operations a... He will resign from our board of,directors shortl...
(Date:5/9/2008)... - Fifth International Phase III Study Shows Po... Data -, NUTLEY, N.J., May 9 /PRNewswire/ ...ew two-year Phase III study showing that ACTEMRA(T...sion of structural damage to,joints in patients wi...f,effectiveness of an RA treatment. The study also...
(Date:5/8/2008)... CLEVELAND, May 8 /- D...chnology and services company focused on global,eC..., today reported its,operating results for the fir...arch 31, 2008, revenue decreased,approximately 41%... of,$(2,233,000), or $(0.16) per share on both a b...
(Date:5/8/2008)... BOSTON, May 8 /- The Cancer Res... the nation,s top cancer centers, is asking,303 mi...r by donating $1 to,cancer research efforts this M...dubbed the "Infinite Power of One(TM)" has two key...atters into their own hands by,joining together to...
Breaking Medicine Technology:Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5First Human Implant of New Archus Orthopedics Facet Replacement System 1879 1First Human Implant of New Archus Orthopedics Facet Replacement System 1879 2Scan Detects Oxygen Levels in Tumors 17519 1Scan Detects Oxygen Levels in Tumors 17519 2Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 1Charity Raffle Offers Trip and Game Tickets to Soccers Euro 2008 Quarterfinal 17517 2Oral PBI 1402 Demonstrates Significant Activity in Chemotherapy Induced Anemia Phase II Clinical Trial 4800 1Oral PBI 1402 Demonstrates Significant Activity in Chemotherapy Induced Anemia Phase II Clinical Trial 4800 2Oral PBI 1402 Demonstrates Significant Activity in Chemotherapy Induced Anemia Phase II Clinical Trial 4800 3
...Phase III Study Results Presented At ASCO -- , CHI...ent with,pegylated interferon alfa-2b in stage III...n relapse-free survival (RFS),according to the re... in patients with stage III melanoma. Results of t...on for the Research and,Treatment of Cancer (EORTC...
...4, 2007 /PRNewswire/ -- A nationally renowned,canc...arch Network,presented a novel study design concep...ethod to accelerate new agent development.,Studies...ed through,the network,s innovative Translational ...onducts early phase trials in a community,setting....
Other Medicine Technology:Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 2Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 3Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 4Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III,Melanoma Demonstrated Significant and Sustained Impact on,Relapse-Free Survival 5Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 2Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 3Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 4Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 5
For the quantitative in vitro determination of IgE in Human Serum or Plasma.
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum.
For the quantitative in vitro determination of Apolipoprotein B in human serum
The GGT method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of g-glutamyl transferase activity in serum and plasma
Medicine Products: